These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31407378)

  • 1. Exonic mutations associated with atopic dermatitis disrupt lympho-epithelial Kazal-type related inhibitor action and enhance its degradation.
    Ramesh K; Matta SA; Chew FT; Mok YK
    Allergy; 2020 Feb; 75(2):403-411. PubMed ID: 31407378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratinocyte-specific mesotrypsin contributes to the desquamation process via kallikrein activation and LEKTI degradation.
    Miyai M; Matsumoto Y; Yamanishi H; Yamamoto-Tanaka M; Tsuboi R; Hibino T
    J Invest Dermatol; 2014 Jun; 134(6):1665-1674. PubMed ID: 24390132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis.
    Fortugno P; Furio L; Teson M; Berretti M; El Hachem M; Zambruno G; Hovnanian A; D'Alessio M
    Hum Mol Genet; 2012 Oct; 21(19):4187-200. PubMed ID: 22730493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor signaling induces the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
    Sugimoto S; Morizane S; Nomura H; Kobashi M; Sugihara S; Iwatsuki K
    J Dermatol Sci; 2018 Nov; 92(2):181-187. PubMed ID: 30270115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-α and IL-17A induce the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
    Sugihara S; Sugimoto S; Tachibana K; Kobashi M; Nomura H; Miyake T; Hirai Y; Yamasaki O; Morizane S
    J Dermatol Sci; 2019 Oct; 96(1):26-32. PubMed ID: 31501002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LEKTI domains D6, D7 and D8+9 serve as substrates for transglutaminase 1: implications for targeted therapy of Netherton syndrome.
    Wiegmann H; Valentin F; Tarinski T; Liebau E; Loser K; Traupe H; Oji V
    Br J Dermatol; 2019 Nov; 181(5):999-1008. PubMed ID: 30801672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological and pathological roles of kallikrein-related peptidases in the epidermis.
    Kishibe M
    J Dermatol Sci; 2019 Aug; 95(2):50-55. PubMed ID: 31279501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor.
    Meyer-Hoffert U; Wu Z; Schröder JM
    PLoS One; 2009; 4(2):e4372. PubMed ID: 19190773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis.
    Chavarria-Smith J; Chiu CPC; Jackman JK; Yin J; Zhang J; Hackney JA; Lin WY; Tyagi T; Sun Y; Tao J; Dunlap D; Morton WD; Ghodge SV; Maun HR; Li H; Hernandez-Barry H; Loyet KM; Chen E; Liu J; Tam C; Yaspan BL; Cai H; Balazs M; Arron JR; Li J; Wittwer AJ; Pappu R; Austin CD; Lee WP; Lazarus RA; Sudhamsu J; Koerber JT; Yi T
    Sci Transl Med; 2022 Dec; 14(675):eabp9159. PubMed ID: 36516271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifaceted Analyses of Epidermal Serine Protease Activity in Patients with Atopic Dermatitis.
    Nomura H; Suganuma M; Takeichi T; Kono M; Isokane Y; Sunagawa K; Kobashi M; Sugihara S; Kajita A; Miyake T; Hirai Y; Yamasaki O; Akiyama M; Morizane S
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LEKTI domain 6 displays anti-inflammatory action in vitro and in a murine atopic dermatitis model.
    Canbolat P; Wilzopolski J; Kaessmeyer S; Filor V; Vidak J; Rüger M; Mägert HJ; Forssmann WG; Bäumer W
    J Dermatol Sci; 2024 Jul; 115(1):13-20. PubMed ID: 38849289
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Park NJ; Jo BG; Bong SK; Park SA; Lee S; Kim YK; Yang MH; Kim SN
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome.
    Briot A; Deraison C; Lacroix M; Bonnart C; Robin A; Besson C; Dubus P; Hovnanian A
    J Exp Med; 2009 May; 206(5):1135-47. PubMed ID: 19414552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant serine protease activities in atopic dermatitis.
    Morizane S; Sunagawa K; Nomura H; Ouchida M
    J Dermatol Sci; 2022 Jul; 107(1):2-7. PubMed ID: 35817663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction.
    Deraison C; Bonnart C; Lopez F; Besson C; Robinson R; Jayakumar A; Wagberg F; Brattsand M; Hachem JP; Leonardsson G; Hovnanian A
    Mol Biol Cell; 2007 Sep; 18(9):3607-19. PubMed ID: 17596512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary effect of hydroquinone and retinoic acid on corneocyte desquamation with their combination use.
    Cheong KA; Lee TR; Lee AY
    J Dermatol Sci; 2017 Aug; 87(2):192-200. PubMed ID: 28433430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of All 34 Exons of the SPINK5 Gene in Japanese Atopic Dermatitis Patients.
    Morizane S; Ouchida M; Sunagawa K; Sugimoto S; Kobashi M; Sugihara S; Nomura H; Tsuji K; Sato A; Miura Y; Hattori H; Tada K; Huh WK; Seno A; Iwatsuki K
    Acta Med Okayama; 2018 Jun; 72(3):275-282. PubMed ID: 29926005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Netherton syndrome: skin inflammation and allergy by loss of protease inhibition.
    Hovnanian A
    Cell Tissue Res; 2013 Feb; 351(2):289-300. PubMed ID: 23344365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incomplete KLK7 Secretion and Upregulated LEKTI Expression Underlie Hyperkeratotic Stratum Corneum in Atopic Dermatitis.
    Igawa S; Kishibe M; Minami-Hori M; Honma M; Tsujimura H; Ishikawa J; Fujimura T; Murakami M; Ishida-Yamamoto A
    J Invest Dermatol; 2017 Feb; 137(2):449-456. PubMed ID: 27769847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum.
    Ishida-Yamamoto A; Deraison C; Bonnart C; Bitoun E; Robinson R; O'Brien TJ; Wakamatsu K; Ohtsubo S; Takahashi H; Hashimoto Y; Dopping-Hepenstal PJ; McGrath JA; Iizuka H; Richard G; Hovnanian A
    J Invest Dermatol; 2005 Feb; 124(2):360-6. PubMed ID: 15675955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.